MedTrace Logo

Probiotics for Treatment of Chalazion in Adults

NCT04342507 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2020-04-14

No results posted yet for this study

Summary

There is growing evidence encouraging probiotics use in several diseases. The aim of the investigator's study is to define the possible beneficial impact of probiotics on adults suffering from chalazia.

Conditions

  • Chalazion

Interventions

OTHER

conservative treatment

lid hygiene, warm compression, and dexamethasone/tobramycin ointment for at least 20 days.

DIETARY_SUPPLEMENT

probiotics

use specific probiotics in addiction to conservative treatment to modify the intestinal microbiome to ameliorate the clinical course of adults chalazia by re-establishing intestinal and immune homeostasis

Sponsors & Collaborators

  • University of Molise

    lead OTHER

Principal Investigators

  • Ciro Costagliola, Full Professor · University of Molise

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04342507 on ClinicalTrials.gov